Paper7296751
Fluorescence assays and pharmacokinetic studies of 4'-deoxydoxorubicin and doxorubicin in organs of mice bearing solid tumors.
Formelli F and 4 others. Cancer Chemother Pharmacol, 1981. Cited by 35 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Fluorescence assays and pharmacokinetic studies of 4'-deoxydoxorubicin and doxorubicin in organs of mice bearing solid tumors. Papers, record 7296751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7296751
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Fluorescence assays and pharmacokinetic studies of 4'-deoxydoxorubicin and doxorubicin in organs of mice bearing solid tumors.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Doxorubicin | Major topic |
| Neoplasms, Experimental | Major topic |
| Animals | |
| Kinetics | |
| Male | |
| Mice | |
| Mice, Inbred BALB C | |
| Spectrometry, Fluorescence | |
| Time Factors | |
| Tissue Distribution |
Source PubMed
References9
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 5527015 | Tissue distribution and disposition of daunomycin (NCS-82151) in mice: fluorometric and isotopic methods. | Cancer Chemother Rep | 1970 | https://conductscience.org/library/papers/5527015 | PubMed |
| 2 | 597963 | Changes of activity of daunorubicin, adriamycin and stereoisomers following the introduction or removal of hydroxyl groups in the amino sugar moiety. | Chem Biol Interact | 1977 | https://conductscience.org/library/papers/597963 | PubMed |
| 3 | 5266065 | Adriamycin: toxicity data. | Experientia | 1970 | https://conductscience.org/library/papers/5266065 | PubMed |
| 4 | 294954 | Fluorescence assay of tissue distribution of 4-demethoxydaunorubicin and 4-demethoxydoxorubicin in mice bearing solid tumors. | Cancer Chemother Pharmacol | 1979 | https://conductscience.org/library/papers/294954 | PubMed |
| 5 | 4715566 | A fluorometric assay for daunomycin and adriamycin in animal tissues. | Biochem Med | 1973 | https://conductscience.org/library/papers/4715566 | PubMed |
| 6 | 206445 | Biologic characterization and chemotherapeutic response of MS-2 tumor: a non-regressing mouse sarcoma derived from MSV-M-induced sarcoma. | Eur J Cancer (1965) | 1978 | https://conductscience.org/library/papers/206445 | PubMed |
| 7 | 1003430 | Synthesis and antitumor activity of 4'-deoxydaunorubicin and 4'-deoxyadriamycin. | J Med Chem | 1976 | https://conductscience.org/library/papers/1003430 | PubMed |
| 8 | 4427218 | Statistical estimations in pharmacokinetics. | J Pharmacokinet Biopharm | 1974 | https://conductscience.org/library/papers/4427218 | PubMed |
| 9 | 5030818 | Comparative pharmacokinetics of daunomycin and adriamycin in several animal species. | Cancer Res | 1972 | https://conductscience.org/library/papers/5030818 | PubMed |
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 35 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38222540 | Improved Targeting and Safety of Doxorubicin through a Novel Albumin Binding Prodrug Approach. | ACS Omega | 2024 | https://conductscience.org/library/papers/38222540 | PubMed |
| 6678877 | Phase I trial with 4'-deoxydoxorubicin (esorubicin). | Invest New Drugs | 1983 | https://conductscience.org/library/papers/6678877 | PubMed |
| 6511235 | Phase I study with 4'-deoxydoxorubicin. | Invest New Drugs | 1984 | https://conductscience.org/library/papers/6511235 | PubMed |
| 4086243 | Human pharmacokinetics of esorubicin (4'-deoxydoxorubicin). | Invest New Drugs | 1985 | https://conductscience.org/library/papers/4086243 | PubMed |
| 4017162 | Pharmacokinetics and disposition of 4'-O-tetrahydropyranyladriamycin in mice by HPLC analysis. | Cancer Chemother Pharmacol | 1985 | https://conductscience.org/library/papers/4017162 | PubMed |
| 3753554 | Comparative pharmacokinetics and metabolism of doxorubicin and 4-demethoxy-4'-O-methyldoxorubicin in tumor-bearing mice. | Cancer Chemother Pharmacol | 1986 | https://conductscience.org/library/papers/3753554 | PubMed |
| 3520474 | Anthracycline antitumour agents. A review of physicochemical, analytical and stability properties. | Pharm Weekbl Sci | 1986 | https://conductscience.org/library/papers/3520474 | PubMed |
| 3484382 | Comparative immunotoxicity of free doxorubicin and doxorubicin encapsulated in cardiolipin liposomes. | Cancer Chemother Pharmacol | 1986 | https://conductscience.org/library/papers/3484382 | PubMed |
| 2948729 | Anthracycline analogs: the past, present, and future. | Cancer Chemother Pharmacol | 1986 | https://conductscience.org/library/papers/2948729 | PubMed |
| 2283890 | Effect of amrinone on anthracycline-induced lethal and cardiac toxicity in mice and rats. | Med Oncol Tumor Pharmacother | 1990 | https://conductscience.org/library/papers/2283890 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7296751
GET https://conductscience.org/api/papers/v1/7296751/authors